Transparency in practice: Evidence from ‘verification analyses’ issued by the Polish Agency for Health Technology Assessment in 2012–2015
Open Access
- 8 January 2018
- journal article
- conference paper
- Published by Cambridge University Press (CUP) in Health Economics, Policy and Law
- Vol. 14 (2) , 182-204
Abstract
Transparency is recognised to be a key underpinning of the work of health technology assessment (HTA) agencies, yet it has only recently become a subject of systematic inquiry. We contribute to this research field by considering the Polish Agency for Health Technology Assessment (AHTAPol). We situate the AHTAPol in a broader context by comparing it with the National Institute for Health and Care Excellence (NICE) in England. To this end, we analyse all 332 assessment reports, called verification analyses, that the AHTAPol issued from 2012 to 2015, and a stratified sample of 22 Evidence Review Group reports published by NICE in the same period. Overall, by increasingly presenting its key conclusions in assessment reports, the AHTAPol has reached the transparency standards set out by NICE in transparency of HTA outputs. The AHTAPol is more transparent than NICE in certain aspects of the HTA process, such as providing rationales for redacting assessment reports and providing summaries of expert opinions. Nevertheless, it is less transparent in other areas of the HTA process, such as including information on expert conflicts of interest. Our findings have important implications for understanding HTA in Poland and more broadly. We use them to formulate recommendations for policymakers.Keywords
This publication has 27 references indexed in Scilit:
- Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodologyBMC Health Services Research, 2012
- SIMILARITIES AND DIFFERENCES BETWEEN FIVE EUROPEAN DRUG REIMBURSEMENT SYSTEMSInternational Journal of Technology Assessment in Health Care, 2012
- The National Institute for Health and Clinical Excellence Single Technology Appraisal Process: Lessons from the First 4 YearsValue in Health, 2011
- Pharmaceutical lobbying under postcommunism: universal or country-specific methods of securing state drug reimbursement in Poland?Health Economics, Policy and Law, 2011
- What aspects of the health technology assessment process recommended by international health technology assessment agencies received the most attention in Poland in 2008?International Journal of Technology Assessment in Health Care, 2011
- From idealistic rookies to a regional leader: The history of health technology assessment in PolandInternational Journal of Technology Assessment in Health Care, 2009
- Key principles for the improved conduct of health technology assessments for resource allocation decisionsInternational Journal of Technology Assessment in Health Care, 2008
- TOWARD TRANSPARENCY IN HEALTH TECHNOLOGY ASSESSMENTInternational Journal of Technology Assessment in Health Care, 2003
- Regulation after delegation: independent regulatory agencies in EuropeJournal of European Public Policy, 2002
- THEORIES OFDELEGATIONAnnual Review of Political Science, 2001